Insight Molecular Diagnostics Inc. (IMDX) Q1 FY26 Earnings Call

Commercial launch is approaching, but near-term revenue remains small while cash burn peaks in Q2.

Q1 FY26 results, source: company transcript and SEC filings
QuarterQ1 FY26
Call date2026-05-14
Length21 minutes
EPS$-0.28
EPS consensus$-0.26
Revenue$32000.00
Revenue consensus$229225.00

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All IMDX earnings ยท Back to IMDX overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.